Composition and methods of paclitaxel for treating psoriasis

Overview

Information

Number
6515016
Application
08/980549
Filing date
12/01/1997
Issue date
02/04/2003
Inventor(s)
William L. Hunter
US Classification
514/449
View at USPTO

Citations

Sanofi-aventis (10)
Bristol-Myers Squibb (5)
ALABAMA AT BIRMINGHAM, UNIVERSITY OF (5)
Merrell Dow Pharmaceuticals (3)
Regents of the University of California, The (3)
NA (3)
Angiotech International (3)
UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (2)
The United States of America as represented by the Department of Health (2)
Thomas Jefferson University (2)
The Johns Hopkins University (2)
Children's Medical Center (2)
Pfizer (2)
Massachusetts Institute Of Technology (2)
Regents Of The University of Minnesota (1)
Hospira (1)
Advanced cardiovascular Systems (1)
HOSTETLER, KARL Y. (1)
Matrix Pharmaceutical (1)
PG-TXL (1)
Chimerix (1)
SPEED GEL (1)
Tapestry Pharmaceuticals (1)
Vestar (1)
Vertex Pharmaceuticals (1)
Rhone-Poulenc Rorer (1)
COOK MEDICAL TECHNOLOGIES (1)
Celgene (1)
Phanos Technologies (1)
Montana State University (1)
Procter & Gamble (1)
Chemex Pharmaceuticals (1)
HOSTETLER FAMILY TRUST (1)
AMO UPPSALA AB (1)

Abstract

Abstract

The present invention provides methods for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.

Assignees with Similar Patents

Referenced by

conextions (20)
bayer intellectual property (10)
IPXMEDICAL, LLC (8)
dfb soria (7)
University of Utah (5)
cardinal health switzerland 515 (5)
COOK MEDICAL TECHNOLOGIES (5)
UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (4)
STATE RESEARCH CENTER FOR APPLIED MICROBIOLOGY & BIOTECHNOLOGY, MINISTRY OF HEALTH & SOCIAL DEVELOPMENT, RF, AS REPRESENTED BY DIRECTOR OF THE STATE RESEARCH CENTER FOR APPLIED MICROBIOLOGY & BIOTECHNOLOGY, MINISTRY OF HEALTH & SOCIAL (3)
Children's Medical Center (2)
Boston Scientific (2)
Massachusetts Institute Of Technology (2)
UNIVERSITY OF BRITISH COLUMBIA, THE (1)
Fidia Farmaceutici S.p.A. (1)
STATE RESEARCH CENTER FOR APPLIED MICROBIOLOGY, MINISTRY OF HEALTH AND SOCIAL DEVELOPMENT,RF, AS REPRESENTED BY THE DIRECTOR FOR THE STATE RESEARCH CENTER FOR APPLIED MICROBIOLOGY,MINISTRY OF HEALTH AND SOCIAL DEVELOPMENT, RF (1)
University of Connecticut (1)
natrogen therapeutics international (1)
dfb soria ll (1)
Intezyne Technologies (1)
Medizinische Hochschule Hannover (1)
state research center applied microbiology biotechnology ministry health social development rf director state research center microbiology biotechnology ministry health social development (1)

Tech Analysis

Class Subclass Type Reference Factor Citation Factor Strength Grant time Early grant (%)
514 449 Emerging Sustaining Seminal Medium Slow 87.9